Evicenter
MarkdownMedical informationP&T meetings
Claseprubart (DNTH103)

Generalized myasthenia gravis

Launch
Not announced
Last updated
120 sources

Product information and disease descriptionProduct description

Phase of product development

10 evidence topics · 9 sources

Launch

No evidence found.

Fast track or breakthrough therapy designation for generalized myasthenia gravis

No evidence found.